India: Big Pharma’s New Promised Land?
For years, software companies have known that they can slash costs by hiring eager, smart, and inexpensive programmers and engineers in India. Following in software’s footsteps, corporations providing telephone support and back-office services soon saw the virtues of India’s well-trained workforce as well. Now, Big Pharma is discovering the same benefits, as multinationals such as Pfizer, GlaxoSmithKline, Bristol-Myers Squibb, and Novartis tap India’s research and manufacturing prowess to cut costs and speed development of new pharmaceuticals.